Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases

World Journal of Gastroenterology

Volumn 10, Issue 9, 2004, Pages 1353-1356

  Bruno, Cosimo Marcello ^a   Neri, Sergio ^a   Sciacca, Claudio ^a   Bertino, Gaetano ^a   Di Prima, Pietro ^a   Cilio, Danila ^a   Pellicano, Rinaldo ^b   Caruso, Luciano ^a   Cristaldi, Raffaello ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; CHRONIC ACTIVE HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; LIVER CIRRHOSIS; MALE; STATISTICAL SIGNIFICANCE; TRANSFERRIN BLOOD LEVEL;

EID: 4444286483     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i9.1353     Document Type: Article

References (29)

1. Pignon JP, Poynard T, Naveau S, Marteau P, Zourabichvili O, Chaput JC. Multidimensional analysis by Cox's model of the survival of patients with alcoholic cirrhosis. Gastroenterol Clin Biol 1986; 10: 461-467
2. Tymofieiev VV, Kolomoiets' MIW. The pathogenetic characteristics of the anemic syndrome in liver cirrhosis. Lik Sprava 1997; 5: 66-71
3. Mehta AB, McIntyre N. Hematological disorders in liver disease. Forum 1998; 8: 8-25
4. Sherlok S, Dooley J. "The haematology of liver disease" in Diseases of the Liver and Biliary System, 11th edition. UK 2002: 47, Oxford: Blackwell Publishing
5. Korolko IUR, Sarycheva TG, Kotelnikov VM, Kozinets GI, Zherebtsov LA. Anemic syndrome in chronic hepatitis and liver cirrhosis. Klin Med 1993; 71: 45-48
6. Spivak JL, Pham T, Isaacs M, Hankins WD. Erythropoietin is both a mitogen and survival factor. Blood 1991; 77: 1228-1233
7. Koury MJ, Bondurant MD. Erythropoietin retards DNA break-down and prevents programmed death in erythroid progenitor cells. Science 1990; 248: 378-381
8. Weatherall DJ, Provan AB. Red cells I: inherited anaemias. Lancet 2000; 355: 1169-1175
9. Scudla V, Adam Z, Scudlova M. Diagnosis and therapy of anemia in chronic diseases. Vnitr Lek 2001; 47: 400-406
10. Spivak JL. The blood in systemic disorders. Lancet 2000; 355: 1707- 1712
11. Siciliano M, Tomasello D, Milani A, Ricerca BM, Storti S, Rossi L. Reduced serum levels of immunoreactive erythropoietin in patients with cirrhosis and chronic anemia. Hepatology 1995; 22: 1132-1135
12. Pirisi M, Fabris C, Falleti E, Soardo G, Toniutto P. Gonano F, Bartoli E. Evidence for a multifactorial control of serum erythropoietin concentration in liver disease. Clin Chim Acta 1993; 219: 47-55
13. Mady E, Wissa G, Khalifa A, el-Sabbagh M. Assessment of erythropoietin levels and some iron indices in chronic renal failure and liver cirrhosis patients. Dis Markers 1999; 15: 229-236
14. Vasilopoulos S. Hally R, Caro J, Martin P, Westerberg S, Moritz M, Jarrel B, Munoz S. Erythropoietin response to post-liver transplantation. Liver Transpl 2000; 6: 349-355
15. Tacke F, Schoffski P, Gauser A, Manus MP. Erythropoietin plasma levels are elevated in chronic liver disease and correlate with anemia, liver dysfunction, bleeding episodes and interleukin-6 (Abstract). J Hepatol 2002; 36: 65
16. Oczko-Grzesik B, Weicek A, Kokot F. Influence of IFN-alpha on plasma erythropoietin levels in patients with hepatitis B virus-associated chronic active hepatitis. J Interferon Cytokine Res 2001; 21: 669-676
17. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietrosi MC, Williams R. "Transection of the esophagus for bleeding esophageal varices" . Br J Surg 1973; 60: 646
18. Colton T. Statistics in Medicine. Boston: Little, Brown and Company, 1973: 201
19. Cazzola M, Mercuriali F, Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood 1997; 89: 4248-4267
20. Jensen JD, Jensen LW, Madsen JK, Poulsen L. The metabolism of erythropoieth, in liver cirrhosis patients compared with healthy volunteers. Eur J Haematol 1995; 54: 111-116
21. Cazzola M, Guarnone R, Cerani P, Centenara E, Rovati A, Beguin Y. Red blood cell precursor mass as an independent determinant of serum erythropoietin level. Blood 1998; 91: 2139-2145
22. Krantz SB. Erythropoietin Blood 1991; 77: 419-434
23. Canbolat O, Fandrey J, Jelkmann W. Effects of modulators of the production and degradation of hydrogen peroxide on erythropoietin syntesis. Respir Physiol 1998; 114: 175-183
24. Fandrey J, Frede S, Jelkmann W. Role of hydrogen peroxide in hypoxia-induced erythropoietin production. Biochem J 1994; 303: 507-510
25. Schobersberger W, Hoffmann G, Fandrey J. Nitric oxide donors suppress erythropoietin production in vitro. Pflugers Arch 1996; 432: 980-985
26. Genius J, Fandrey J. Nitric oxide affects the production of reactive oxygen species in hepatoma cells: implications for the process of oxygen sensing. Free Radic Biol Med 2000; 29: 515-521
27. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992; 79: 1987-1994
28. Jelkmann WE, Fandrey J, Frede S, Pagel H. Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states. Ann N Y Acad Sci 1994; 718: 300-309
29. Poveda Gomez F, Camacho Siles J, Quevedo Morales E, Fernandez Zamorano A, Codoceo Alquinta R, Arnalich Fernandez F, Sempere Alcocer M. Pattern of blood levels of erythropoietin and proinflammatory cytokines in patients with anemia of chronic disorders secondary to infection. An Med Interna 2001; 18: 298-304